Von Hippel-Lindau Syndrome: Demonstration of Entire Disease Spectrum with 68Ga-DOTANOC PET-CT.
10.3348/kjr.2014.15.1.169
- Author:
Punit SHARMA
1
;
Varun Singh DHULL
;
Chandrasekhar BAL
;
Arun MALHOTRA
;
Rakesh KUMAR
Author Information
1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. dr_punitsharma@yahoo.com
- Publication Type:Case Reports
- Keywords:
Von Hippel-Lindau syndrome;
68Ga-DOTANOC;
PET-CT;
Hemangioblastoma;
RCC;
NET
- MeSH:
Brain Diseases/radionuclide imaging;
Female;
Humans;
Kidney Diseases/radionuclide imaging;
Liver Diseases/radionuclide imaging;
Middle Aged;
Multimodal Imaging/*methods;
Organometallic Compounds/diagnostic use;
Pancreatic Diseases/radionuclide imaging;
Positron-Emission Tomography/*methods;
Tomography, X-Ray Computed/*methods;
von Hippel-Lindau Disease/*radionuclide imaging
- From:Korean Journal of Radiology
2014;15(1):169-172
- CountryRepublic of Korea
- Language:English
-
Abstract:
Von Hippel-Lindau (VHL) syndrome is a rare neoplastic disorder characterized by central nervous system (CNS) and visceral tumors. We here present 68Ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-Nal3-Octreotide positron emission tomography computed tomography findings in a 52 year old female with VHL syndrome, demonstrating both CNS and visceral tumors.
